Skip to content

Impact of No-touch Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma

Impact of No-touch Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06331273
Enrollment
800
Registered
2024-03-26
Start date
2024-04-01
Completion date
2028-04-01
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma, Liver Transplantation, No-touch Technique

Brief summary

The no-touch technique has been one of the most important principles of oncological surgery and aimed to prevent seeding and tumor cell dissemination. Previous studies in hepatectomy have shown that no-touch technique surgery can reduce HCC recurrence and improve the survival of patients. However, there is no consensus on whether the no-touch technique in LT for HCC improves the outcomes. This study aims to prospectively include liver transplant patients from multiple transplant centers, collecting their pre-transplant clinical information, post-transplant pathological records and exploring and clarify the correlation between no-touch technique and the prognosis of LT patients.

Interventions

PROCEDURELiver transplantation with No-touch technique

The core principle of no-touch tumor surgery revolves around avoiding direct contact with the tumor or surrounding tissues as much as possible to minimize the release of cancer cells into the bloodstream or nearby tissues.

Sponsors

Shulan (Hangzhou) Hospital
CollaboratorOTHER
Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of HCC based on CT or MRI imaging or needle biopsy confirming a histologic diagnosis of HCC. 2. Patients undergoing deceased donor liver transplantation for the first time.

Exclusion criteria

(1) patients who received split LT or simultaneous transplantation, (2) patients who received re-transplantation, (3) patients with macroscopic portal vein tumor thrombosis or other macrovascular invasion, (4) patients with incomplete follow-up or incomplete important parameters records.

Design outcomes

Primary

MeasureTime frame
Recurrence free surviavl rate2024.4.1-2028.4.1
Overall survival rate2024.4.1-2028.4.1
Tumor recurrence rate2024.4.1-2028.4.1

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026